Koyfin Home > Directory > Health Care > Amgen Inc > EBITDA / Interest Expenses

Amgen Inc EBITDA / Interest Expenses Chart (AMGN)

Amgen Inc annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Amgen Inc EBITDA / Interest Expenses for the quarter ending September 09, 2020 was $11m a 27.62% increase of 3m year over year
  • Amgen Inc EBITDA / Interest Expenses for the last 12 months ending September 09, 2020 was $10m a 6.64% increase of 1m year over year
  • Amgen Inc Annual EBITDA / Interest Expenses for 2019 was $9m a 3.10% increase of 0m from 2018
  • Amgen Inc Annual EBITDA / Interest Expenses for 2018 was $9m a -4.80% decrease of 0m from 2017
  • Amgen Inc Annual EBITDA / Interest Expenses for 2017 was $9m a -0.90% decrease of 0m from 2016
Other Ratios Metrics:
  • Amgen Inc Total Debt / Capital for the quarter ending December 12, 2018 was $73m a 4.94% increase of 4m year over year
  • Amgen Inc Other Liabilities for the quarter ending December 12, 2018 was $10,918m a -7.23% decrease of -789m year over year
  • Amgen Inc Total Debt / Equity for the quarter ending December 12, 2018 was $271m a 16.17% increase of 44m year over year
View Chart On Koyfin

Quarterly AMGN EBITDA / Interest Expenses Data

09/2020$11m
06/2020$11m
03/2020$9m
12/2019$8m
09/2019$10m
06/2019$10m
03/2019$9m
12/2018$8m
09/2018$9m
06/2018$10m

Annual AMGN EBITDA / Interest Expenses Data

2019$9m
2018$9m
2017$9m
2016$9m
2015$10m
2014$8m
2013$7m
2012$7m
2011$10m
2010$11m